Cargando…
Evaluation of the clinical efficacy of 1.2% atorvastatin in the treatment of periodontal intraosseous defects by CBCT: A randomized controlled clinical trial
Background. Atorvastatin (ATV), which belongs to the statin class of drugs, is the formidable inhibitor of 3-hydroxy-2- methyl-glutaryl coenzyme A reductase. This clinical trial evaluated and compared the clinical and radiographic changes in chronic periodontitis (CP) patients, obtained through 1.2%...
Autores principales: | Shirke, Prerna Y., Kolte, Abhay P., Kolte, Rajashri A., Bawanakar, Pranjali V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tabriz University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904913/ https://www.ncbi.nlm.nih.gov/pubmed/31857864 http://dx.doi.org/10.15171/joddd.2019.029 |
Ejemplares similares
-
Assessment of knowledge, awareness, and attitude among patients with cardiovascular disease about its association with chronic periodontitis
por: Bawankar, Pranjali Vijaykumar, et al.
Publicado: (2021) -
Clinical and postextraction evaluation of periodontal disease indicators
por: Kolte, Rajashri, et al.
Publicado: (2016) -
Effect of Nonsurgical Periodontal Therapy on Metabolic Control and Systemic Inflammatory Markers in Patients of Type 2 Diabetes Mellitus with Stage III Periodontitis
por: Kolte, Rajashri Abhay, et al.
Publicado: (2023) -
Quantitative estimation and correlation of serum albumin levels in clinically healthy subjects and chronic periodontitis patients
por: Kolte, Rajashri A., et al.
Publicado: (2010) -
Patient-centered outcome measures comparing the autogenous and allogenic bone blocks in the augmentation of deficient alveolar ridges: A pilot study
por: Bawankar, Pranjali Vijaykumar, et al.
Publicado: (2023)